These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 17724075)
1. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis. Triccas JA; Shklovskaya E; Spratt J; Ryan AA; Palendira U; Fazekas de St Groth B; Britton WJ Infect Immun; 2007 Nov; 75(11):5368-75. PubMed ID: 17724075 [TBL] [Abstract][Full Text] [Related]
2. Co-immunization with DNA vaccines expressing granulocyte-macrophage colony-stimulating factor and mycobacterial secreted proteins enhances T-cell immunity, but not protective efficacy against Mycobacterium tuberculosis. Kamath AT; Hanke T; Briscoe H; Britton WJ Immunology; 1999 Apr; 96(4):511-6. PubMed ID: 10233735 [TBL] [Abstract][Full Text] [Related]
3. Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis. Mollenkopf HJ; Grode L; Mattow J; Stein M; Mann P; Knapp B; Ulmer J; Kaufmann SH Infect Immun; 2004 Nov; 72(11):6471-9. PubMed ID: 15501778 [TBL] [Abstract][Full Text] [Related]
4. Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis. McShane H; Brookes R; Gilbert SC; Hill AV Infect Immun; 2001 Feb; 69(2):681-6. PubMed ID: 11159955 [TBL] [Abstract][Full Text] [Related]
5. Early secreted antigen ESAT-6 of Mycobacterium tuberculosis promotes protective T helper 17 cell responses in a toll-like receptor-2-dependent manner. Chatterjee S; Dwivedi VP; Singh Y; Siddiqui I; Sharma P; Van Kaer L; Chattopadhyay D; Das G PLoS Pathog; 2011 Nov; 7(11):e1002378. PubMed ID: 22102818 [TBL] [Abstract][Full Text] [Related]
6. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Kamath AT; Feng CG; Macdonald M; Briscoe H; Britton WJ Infect Immun; 1999 Apr; 67(4):1702-7. PubMed ID: 10085007 [TBL] [Abstract][Full Text] [Related]
7. A recombinant bovine adenoviral mucosal vaccine expressing mycobacterial antigen-85B generates robust protection against tuberculosis in mice. Khan A; Sayedahmed EE; Singh VK; Mishra A; Dorta-Estremera S; Nookala S; Canaday DH; Chen M; Wang J; Sastry KJ; Mittal SK; Jagannath C Cell Rep Med; 2021 Aug; 2(8):100372. PubMed ID: 34467249 [TBL] [Abstract][Full Text] [Related]
8. Exposure to human alveolar lining fluid enhances Mycobacterium bovis BCG vaccine efficacy against Mycobacterium tuberculosis infection in a CD8 Moliva JI; Hossfeld AP; Canan CH; Dwivedi V; Wewers MD; Beamer G; Turner J; Torrelles JB Mucosal Immunol; 2018 May; 11(3):968-978. PubMed ID: 28930287 [TBL] [Abstract][Full Text] [Related]
9. Protective effect of DNA immunization against mycobacterial infection is associated with the early emergence of interferon-gamma (IFN-gamma)-secreting lymphocytes. Kamath AT; Groat NL; Bean AG; Britton WJ Clin Exp Immunol; 2000 Jun; 120(3):476-82. PubMed ID: 10844526 [TBL] [Abstract][Full Text] [Related]
10. The 19-kD antigen and protective immunity in a murine model of tuberculosis. Yeremeev VV; Lyadova IV; Nikonenko BV; Apt AS; Abou-Zeid C; Inwald J; Young DB Clin Exp Immunol; 2000 May; 120(2):274-9. PubMed ID: 10792376 [TBL] [Abstract][Full Text] [Related]
11. Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family. Dillon DC; Alderson MR; Day CH; Lewinsohn DM; Coler R; Bement T; Campos-Neto A; Skeiky YA; Orme IM; Roberts A; Steen S; Dalemans W; Badaro R; Reed SG Infect Immun; 1999 Jun; 67(6):2941-50. PubMed ID: 10338503 [TBL] [Abstract][Full Text] [Related]
12. Enhanced immune response and protective effects of nano-chitosan-based DNA vaccine encoding T cell epitopes of Esat-6 and FL against Mycobacterium tuberculosis infection. Feng G; Jiang Q; Xia M; Lu Y; Qiu W; Zhao D; Lu L; Peng G; Wang Y PLoS One; 2013; 8(4):e61135. PubMed ID: 23637790 [TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Flynn JL; Goldstein MM; Triebold KJ; Koller B; Bloom BR Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12013-7. PubMed ID: 1465432 [TBL] [Abstract][Full Text] [Related]
14. Genes for immunodominant protein antigens are highly homologous in Mycobacterium tuberculosis, Mycobacterium africanum, and the vaccine strain Mycobacterium bovis BCG. Lu MC; Lien MH; Becker RE; Heine HC; Buggs AM; Lipovsek D; Gupta R; Robbins PW; Grosskinsky CM; Hubbard SC Infect Immun; 1987 Oct; 55(10):2378-82. PubMed ID: 2820881 [TBL] [Abstract][Full Text] [Related]
15. Recombinant BCG as a vaccine vehicle to protect against tuberculosis. Triccas JA Bioeng Bugs; 2010; 1(2):110-5. PubMed ID: 21326936 [TBL] [Abstract][Full Text] [Related]